Doceree · 2 days ago
Director - Sales & Partnerships
Doceree is the leading Global network for HCP-only programmatic messaging, reshaping how pharmaceutical brands and healthcare agencies connect with physicians. The Director – Sales & Partnerships will drive growth with pharma companies and advertising agencies, owning the full sales cycle and exceeding revenue targets while ensuring exceptional client experiences.
Responsibilities
Win new business and expand strategic partnerships with top pharma brands and advertising agencies
Own the full sales cycle - from prospecting to closing high-value, long-term deals
Exceed revenue targets while delivering an exceptional client experience
Partner with Customer Success and internal teams to ensure flawless campaign delivery and performance
Unlock upsell opportunities, strengthen relationship and feed valuable market insights back to product teams
Position Doceree is the only AI-powered operating system for healthcare marketing
Qualification
Required
5+ years in healthcare/pharma advertising sales with proven track record of exceeding targets
Strong existing relationships with top healthcare agencies and pharma companies decision makers
Expert in HCP digital marketing, healthcare media and programmatic advertising
Skilled at building executive-level partnerships and navigating complex, consultative sales cycles
Driven, motivated, and passionate about shaping the future of HCP advertising while unlocking unlimited earning potential
Benefits
Competitive salary and uncapped commission plan
Stellar health care plan options for you and your family (Medical, Dental & Vision)
401K + 4% Matching
Generous PTO, vacations & sick leave
Extensive paid parental/maternity leave
Team events
Company
Doceree
Doceree provides marketing solutions for pharmaceutical and healthcare brands to connect with healthcare professionals (HCPs).
Funding
Current Stage
Growth StageTotal Funding
$64.81MKey Investors
CreaegisF-PrimeAjai Joneja
2024-10-17Undisclosed· $4.21M
2023-09-27Series B· $48.6M
2022-04-06Series A· $11M
Recent News
2025-12-24
2025-10-16
Company data provided by crunchbase